Document is current
Any future updates will be listed below
-
Authors
Pijnenburg, Lisa J. https://orcid.org/0000-0002-5498-8371
Kaplun, Anais
de Haan, Lieuwe
Janecka, Magdalena
Smith, Lauren
Reichenberg, Abraham
Banaschewski, Tobias
Bokde, Arun L. W.
Quinlan, Erin Burke
Desrivières, Sylvane
Grigis, Antoine
Garavan, Hugh
Gowland, Penny
Heinz, Andreas
Ittermann, Bernd
Martinot, Jean-Luc
Martinot, Marie-Laure Paillère
Nees, Frauke
Orfanos, Dimitri Papadopoulos
Paus, Tomáš
Poustka, Luise
Hohmann, Sarah
Millenet, Sabina
Fröhner, Juliane H.
Smolka, Michael N.
Walter, Henrik
Whelan, Robert
Schumann, Gunter
Velthorst, Eva
,
-
Funding
Funding for this research was provided by:
Sixth Framework Programme (LSHM-CT-2007-037286)
- License Information
-
More Information
Article History
Received: 11 October 2021
Accepted: 3 March 2022
First Online: 23 March 2022
Declarations
:
: The authors declare that there is no conflict of interest. Dr. Banaschewski served in an advisory or consultancy role for Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Shire. He received conference support or speaker’s fee by Lilly, Medice, Novartis and Shire. He has been involved in clinical trials conducted by Shire & Viforpharma. He received royalties from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press. The present work is unrelated to the above grants and relationships. The other authors report no biomedical financial interests or potential conflicts of interest.
